Recurrence and Emergence of New Primary Tumors in Patients with Resected Pathological Stage 1A Non–Small Cell Lung Cancer
Annals of the American Thoracic Society · 2026
DOI: 10.1513/annalsats.202501-121oc ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the American Thoracic Society, 2026. Verfasst von Louis Gros und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic, Molecular, and Interventional Radiology. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Recurrence, Local, Neoplasms, Second Primary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Rationale
Lung cancer screening has made early-stage non–small cell lung cancer (NSCLC) more common and highly curable. However, evidence on post-treatment surveillance, new radiological findings, and distinguishing recurrence from new primary cancers remains limited.
Objectives
Our study evaluated outcomes in patients with pathologic stage 0/1A first primary NSCLC after surgery, including overall survival and the classification of new findings as either recurrence or second primary tumors. We also explored potential improvements to current classification criteria.
Methods
We analyzed 653 patients with pathologic stage 0/1A NSCLC from the IELCART cohort (2016–2023). Radiological findings were reviewed to classify lung cancer diagnoses as second primaries or recurrences using a five-step approach based on histopathology, genetics, timing, and multidisciplinary discussions. Survival was analyzed with Kaplan-Meier curves and log-rank tests.
Results
Among 653 patients (61.1% women, median age 69 yr), 74 (11.3%) later had radiological findings confirmed as lung cancer, which was more frequent in men (15.7% vs. 8.5%), those with higher pack-years, and chronic obstructive pulmonary disease. New malignant events were most common in current smokers (19.1%), followed by former smokers (15.2%) and never smokers (1.6%). Of these, 30 (5%) were second primaries, and 44 (7%) were recurrences. Nonsolid cancers showed no recurrences. Recurrences peaked at 12–18 months, whereas second primaries occurred steadily at 0.6% annually. Overall survival differed significantly between patient groups (P < 0.0001), with overall survival of 58.2% with recurrences, 77.9% with new primaries, and 94.3% with no new cancer after a median follow-up of 3.5 years.
Conclusion
Among 653 patients, 7% had recurrences, whereas new primaries (5%) became more frequent after 3 years, occurring steadily at 0.6% per year, with distinct survival outcomes. New malignant events were more common in men, smokers, and those with chronic obstructive pulmonary disease. Notably, all malignancies in nonsolid cancers were new primaries. These findings emphasize the need for tailored surveillance strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic, Molecular, and Interventional Radiology.
- Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
- Department of Thoracic Surgery, and.
- Tisch Cancer Institute and Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York; and.
ORCID-Profile: Louis Gros
Zitieren
APA
Gros, L., Yip, R., Flores, R. M., Paksashvili, N., Zhang, L., Lyu, L., Cai, S., Taioli, E., Yankelevitz, D. F., Henschke, C. I., & IELCART Investigators (2026). Recurrence and Emergence of New Primary Tumors in Patients with Resected Pathological Stage 1A Non–Small Cell Lung Cancer. Annals of the American Thoracic Society. https://doi.org/10.1513/annalsats.202501-121oc
Vancouver
Gros L, Yip R, Flores RM, Paksashvili N, Zhang L, Lyu L, et al. Recurrence and Emergence of New Primary Tumors in Patients with Resected Pathological Stage 1A Non–Small Cell Lung Cancer. Annals of the American Thoracic Society. 2026. doi:10.1513/annalsats.202501-121oc
BibTeX
@article{Gros2026,
author = {Gros, Louis and Yip, Rowena and Flores, Raja M and Paksashvili, Natela and Zhang, Lijing and Lyu, Lyu and Cai, Siyang and Taioli, Emanuela and Yankelevitz, David F and Henschke, Claudia I and IELCART Investigators, IELCART Investigators},
title = {Recurrence and Emergence of New Primary Tumors in Patients with Resected Pathological Stage 1A Non–Small Cell Lung Cancer},
journal = {Annals of the American Thoracic Society},
year = {2026},
doi = {10.1513/annalsats.202501-121oc}
}
EUVIMED